Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (4835)	7/10/1998 8:41:00 AM
From: Intel Trader	Read Replies (1) of 6136

Good job V-1. I'd much rather be long AGPH than short it. The short money has already been made. There are much better situations for shorts to make money in (check out IPIC and similar one-product-wonders that fizzle to single digits). It is very dangerous for shorts to enter and stay in a good company for a long while. An example: While there is no possible way to compare the two, YHOO is an interesting anecdotal short story. I'm aware of someone who believing that YHOO was overvalued at $100 shorted one thousand shares. That person, believing that YHOO was overvalued, continued to pay margin calls over a period of months. Guess where they covered recently: $190, for a $90,000.00 LOSS!!!!! There are still people who are short MSFT for ex from $45, and that was before the split! Believe me, there are many other companies that I'd rather short. AGPH is not one of them, having a potential of rising 20 points in a day if something positive arises. As for TheStreet.Com, they have about 2-3 writers who are worth a darn. As for JJC, ask yourself whether you'd like to have him trade your money in his hedge fund. Regards, it

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next